Skip to main content
SpringerLink
Log in

Effects of verapamil on myocardial stunning in xanthineoxidase deficient hearts: Pre-treatment vs. post-ischemic treatment

  • Original Contributions
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Summary

The role of free radicals and the protective action of calcium antagonists have been established in myocardial stunning in canine hearts, which contain a considerable level of xanthine oxidase, a free radical producing enzyme. However, myocardial stunning in hearts which lack xanthine oxidase and its modification by calcium antagonistsin vivo remain uncharacterized. The present study examined this issue using open-chest anesthetized rabbits. Myocardial stunning was induced by a 10-min coronary occlusion and reperfusion. Regional systolic thickening fraction (TF) was determined using an epicardial Doppler sensor, together with other hemodynamic parameters. In untreated control rabbits, recovery of TF from the 10 min transient ischemia was 43±3% of the baseline at 30 min after reperfusion. Administration of verapamil (200 μg/kg bolus plus 40 μg/kg/min), which was started before the onset of ischemia and continued until 20 min after reperfusion, significantly improved the recovery of TF to 74±6% (p<0.05). A similar improvement in post-ischemic contractile function (TF=77±10%) was observed when verapamil was injected at the same rate, but the infusion was discontinued 1 min after the coronary occlusion. Myocardial ATP depletion after the 10 min ischemia was significantly less in the verapamil-pretreated rabbits compared with untreated controls (10.1±1.0 vs 6.2±0.7 μmol/g dry wt., p<0.05). The difference in TF between the rabbits with and without verapamil treatment could not be explained by afterload reduction. When verapamil (100 μg/kg bolus plus 20 μg/kg/min) was given during the reperfusion period alone, TF recovery was poorer (TF=22±8%) than the control value. Thus, it was concluded that verapamil attenuates myocardial stunning in the hearts with trace levels of xanthine oxidase, and that the beneficial effect is achieved only by pretreatment, not by post-ischemic treatment with verapamil.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bolli R (1990) Mechanism of myocardial stunning. Circulation 82:723–738

    Google Scholar 

  2. Kloner RA, Przyklenk K (1991) Stunned and hibernating myocardium. Ann Rev Med 42:1–8

    Google Scholar 

  3. Heusch G (1992) Myocardial stunning: a role for calcium antagonists during ischemia? Cardiovasc Res 26:14–19

    Google Scholar 

  4. Opie L (1992) Myocardial stunning: a role for calcium antagonists during reperfusion? Cardiovasc Res 26:20–24

    Google Scholar 

  5. Parks DA, Granger DN (1986) Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand 126 (Suppl 548):87–100

    Google Scholar 

  6. Chambers DE, Parks DA, Patterson G, Roy R, Mc Cord JM, Yoshida S, Parmly LF, Downey JM (1985). Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 17:145–152

    Google Scholar 

  7. Bersohn MM, Shine KI (1983) Verapamil protection of ischemic isolated rabbit heart: Dependence on pretreatment. J Mol Cell Cardiol 15:659–671

    Google Scholar 

  8. Watts JA, Maiorano LJ, Maiorano PC (1985) Protection of the effects by verapamil of globally ischemic rat hearts: Energy preservation, a partial explanation. J Mol Cell Cardiol 17:797

    Google Scholar 

  9. Rohmann S, Schott RJ, Harting J, Schaper W (1991) Ischemic preconditioning is not a function of stunned myocardium. J Mol Cell Cardiol 23 (suppl V):71 (Abstract)

    Google Scholar 

  10. Verdouw PD, Wolffenbuttel BHR, Ten Cate FJ (1983) Nifedipine with and without propranolol in the treatment of myocardial ischemia: effect on ventricular arrhythmias and recovery of regional wall function. Eur Heart J 4 (Suppl C):101–108

    Google Scholar 

  11. Eddy LJ, Stewart JR, Jones H, Engerson TD, McCord JM, Downey JM (1987) Free radical producing enzyme, xanthine oxidase, is undetectable in human heart. Am J Physiol 253:H709-H711

    Google Scholar 

  12. Muxfeldt M, Schaper W (1987) The activity of xanthine oxidase in heart of pigs, guinea pigs, rabbits, rats, and humans. Basic Res Cardiol 82:486–492

    Google Scholar 

  13. Downey JM, Miura T, Eddy LJ, Chambers DE, Mellert T, Hearse DJ, Yellon DM (1987) Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J Mol Cell Cardiol 19:1053–1060

    Google Scholar 

  14. Przyklenk K, Kloner RA (1988) Effect of verapamil on post-ischemic stunned myocardium: Importance of the timing of treatment. J Am Coll Cardiol 11:614–623

    Google Scholar 

  15. Przyklenk K, Ghafari GB, Eitzman DT, Kloner RA (1989) Nifedipine administered after reperfusion abaltes systolic contractile disfunction of postischemic stunned myocardium. J Am Coll Cardiol 13:1176–1183

    Google Scholar 

  16. Ehring T, Bohm M, Heusch G (1992) The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia. J Cardiovasc Pharmacol 20:63–74

    Google Scholar 

  17. Przyklenk K, Kloner RA (1992) Calcium antagonists and the stunned myocardium: a role during ischemia? A role during reperfusion? Cardiovasc Res 26:82–84

    Google Scholar 

  18. Ooiwa H, Miura T, Iwamoto T, Ogawa T, Ishimoto R, Adachi T, Iimura O (1992) Superoxide dismutase attenuated post-ischaemic contractile dysfunction in a myocardial xanthine oxidase deficient species. Clin Exp Pharmacol Physiol 19:119–125

    Google Scholar 

  19. Miura T, Goto M, Urabe K, Endoh A, Shimamoto K, Iimura O (1991) Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning? Circulation 84:2504–2512

    Google Scholar 

  20. Zhu WX, Myers ML, Hartley CJ, Roberts R, Bolli R (1986) Validation of a single crystal for measurement of transmural and epicardial thickening. Am J Physiol 251 (Heart Circ Physiol 20):H1045-H1055

    Google Scholar 

  21. Bergmyer HU (1963) Methods in Enzymatic Analysis, Academic Press, New York

    Google Scholar 

  22. Glantz SA (1987) Primer of biostatistics. Second ed. McGraw-Hill Inc, New York pp 265–276

    Google Scholar 

  23. Kirk RE (1968) Experimental design: procedures for the behavioral sciences. Brooks/Cole Publishing Company, Belmont, pp 245–318

    Google Scholar 

  24. Miura T, Downey JM, Ooiwa H, Ogawa S, Adachi T, Noto T, Shizukuda Y, Iimura O (1989) Progression of myocardial infarction in a collateral flow deficient species. Jpn Heart J 30:695–708

    Google Scholar 

  25. Charlat ML, O'Neill PG, Egan JM, Abernethy DR, Michael LH, Myers ML, Roberts R, Bolli R (1987) Evidence for a pathogenetic role of xanthine oxidase in the “stunned‘ myocardium. Am J Physiol 252:H566–577

    Google Scholar 

  26. Puett DW, Forman MB, Cates CU, Wilson BH, Hande KR, Fresinger GC, Virmani R (1987) Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion. Circulation 76:678–686

    Google Scholar 

  27. Watts JA, Maiorano LJ, Maiorano PC (1986) Comparison of the protective effects of verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injury. J Mol Cell Cardiol 18:255–263

    Google Scholar 

  28. Lange R, Ingwall J, Hale S, Alker, KJ, Braunwald E, Kloner RA (1984) Preservation of high energy phosphates by verapamil in reperfused myocardium. Circulation of high enery phosphates by verapamil in reperfused myocardium. Circulation 70:734–741

    Google Scholar 

  29. Neely JR, Grotyohann LW (1984) Role of glycolytic products in damage to ischemic myocardium: Dissociation of adenosine triphosphate levels and recovery of function reperfused of ischemic hearts. Circ Res 55:816–824

    Google Scholar 

  30. Przyklenk K, Kloner RA (1986) Superoxide dismutase plus catalase improve contractile function in the canine model of the “stunned” myocardium. Circ Res 58:148–156

    Google Scholar 

  31. Hoffmeister HM, Mauser M, Schaper W (1985) Effect of adenosine and AICAR on ATP content and regional contractile function in reperfused canine myocardium. Basic Res Cardiol 80:445–458

    Google Scholar 

  32. Stahl K, Aversano T, Becker L (1986) Selective enhancement of function of stunned myocardium by increased flow. Circulation 74:843–51

    Google Scholar 

  33. Lamping KA, Gross GJ (1985) Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicroandil, a potential new antianginal agent, and nifedipine. J Cardiovasc Pharmacol 7:158–156

    Google Scholar 

  34. Taylor AL, Golino P, Eckels R, Pastor P, Buja M, Willerson JT (1990) Differential enhancement of postischemic segmental systolic shortening by diltiazem. J Am Coll Cardiol 15:737–747

    Google Scholar 

  35. Kusuoka H, Poterfield JK, Weisman HF, Weisfeldt ML, Marban E (1987) Pathophysiology and pathogenesis of stunned myocardium: Depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret heart. J Clin Invest 79:950–961

    Google Scholar 

  36. Kusuoka H, Koretsune Y, Chacko VP, Weisfeldt ML, Marban E (1990) Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca2+ transients underlie stunning? Circ Res 66:1268–1276

    Google Scholar 

  37. Du Toit EF, Opie LH (1992) Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res 70:960–967

    Google Scholar 

Download references

Author information

Author notes

  1. T. Miura

    Present address: Second Department of Internal Medicine, Sapporo Medical University, School of Medicine, S-1 W-16 Chuo-ku, 060, Sapporo, Japan

Authors and Affiliations

  1. Second Department of Internal Medicine, Sapporo Medical University, School of Medicine, S-1 W-16 Chuo-ku, 060, Sapporo, Japan

    T. Adachi, K. Suzuki & O. Iimura

Authors
  1. T. Adachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Iimura
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adachi, T., Miura, T., Suzuki, K. et al. Effects of verapamil on myocardial stunning in xanthineoxidase deficient hearts: Pre-treatment vs. post-ischemic treatment. Basic Res Cardiol 89, 16–28 (1994). https://doi.org/10.1007/BF00788674

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00788674

Key words

Search

Navigation